Immunitybio (IBRX) had the highest return between January 14, 2026 and January 21, 2026 by a mid-cap US stock, returning 131.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunitybio (IBRX) | 1/14/2026 - 1/21/2026 | 131.44% |
Amylyx Pharmaceuticals (AMLX) | 1/14/2026 - 1/21/2026 | 34.18% |
Erasca (ERAS) | 1/14/2026 - 1/21/2026 | 33.64% |
Rambus (RMBS) | 1/14/2026 - 1/21/2026 | 31.89% |
Argan (AGX) | 1/14/2026 - 1/21/2026 | 26.8% |
Ultra Clean (UCTT) | 1/14/2026 - 1/21/2026 | 26.34% |
Stagwell (STGW) | 1/14/2026 - 1/21/2026 | 24.36% |
Immunome (IMNM) | 1/14/2026 - 1/21/2026 | 23.36% |
GPGI (GPGI) | 1/14/2026 - 1/21/2026 | 21.19% |
Uranium Energy (UEC) | 1/14/2026 - 1/21/2026 | 21.03% |
Figure Technology Solutions, Inc Class A Common Stock (FIGR) | 1/14/2026 - 1/21/2026 | 20.77% |
Galaxy Digital (GLXY) | 1/14/2026 - 1/21/2026 | 20.14% |
Tango Therapeutics (TNGX) | 1/14/2026 - 1/21/2026 | 20.06% |
Matson (MATX) | 1/14/2026 - 1/21/2026 | 19.2% |
Vishay Intertechnology (VSH) | 1/14/2026 - 1/21/2026 | 19.06% |
Edgewise Therapeutics (EWTX) | 1/14/2026 - 1/21/2026 | 17.57% |
Biohaven (BHVN) | 1/14/2026 - 1/21/2026 | 17.53% |
Vicor (VICR) | 1/14/2026 - 1/21/2026 | 17.35% |
ServisFirst Bancshares (SFBS) | 1/14/2026 - 1/21/2026 | 16.66% |
FormFactor (FORM) | 1/14/2026 - 1/21/2026 | 16.37% |
Sprott (SII) | 1/14/2026 - 1/21/2026 | 16.12% |
USA Rare Earth (USAR) | 1/14/2026 - 1/21/2026 | 15.96% |
Alkermes (ALKS) | 1/14/2026 - 1/21/2026 | 15.69% |
Definium Therapeutics (DFTX) | 1/14/2026 - 1/21/2026 | 15.41% |
Solstice Advanced Materials (SOLS) | 1/14/2026 - 1/21/2026 | 15.33% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.